GR1010617B - Αναστολεις της προλυλικης ολιγοπεπτιδασης (ρορ) για χρηση στην προληψη και στην αντιμετωπιση του συνδρομου οξειας αναπνευστικης δυσχερειας (ards) - Google Patents
Αναστολεις της προλυλικης ολιγοπεπτιδασης (ρορ) για χρηση στην προληψη και στην αντιμετωπιση του συνδρομου οξειας αναπνευστικης δυσχερειας (ards) Download PDFInfo
- Publication number
- GR1010617B GR1010617B GR20220101078A GR20220101078A GR1010617B GR 1010617 B GR1010617 B GR 1010617B GR 20220101078 A GR20220101078 A GR 20220101078A GR 20220101078 A GR20220101078 A GR 20220101078A GR 1010617 B GR1010617 B GR 1010617B
- Authority
- GR
- Greece
- Prior art keywords
- ards
- pop
- inhibitors
- prevention
- treatment
- Prior art date
Links
- 101001095266 Homo sapiens Prolyl endopeptidase Proteins 0.000 title abstract 3
- 102000056251 Prolyl Oligopeptidases Human genes 0.000 title abstract 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 abstract 1
- 229940074391 gallic acid Drugs 0.000 abstract 1
- 235000004515 gallic acid Nutrition 0.000 abstract 1
- 239000003649 prolyl endopeptidase inhibitor Substances 0.000 abstract 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 abstract 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε συνθέσεις που περιέχουν μία δραστική ουσία ή μείγμα δραστικών ουσιών οι οποίες είναι αναστολείς της προλυλικής ολιγοπεπτιδάσης (POP), για χρήση στην πρόληψη και την αντιμετώπιση του συνδρόμου οξείας αναπνευστικής δυσχέρειας (ARDS), όπου ο αναστολέας της προλυλικής ολιγοπεπτιδάσης επιλέγεται ανάμεσα σε ροσμαρινικό οξύ και γαλλικό οξύ.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20220101078A GR1010617B (el) | 2022-12-23 | 2022-12-23 | Αναστολεις της προλυλικης ολιγοπεπτιδασης (ρορ) για χρηση στην προληψη και στην αντιμετωπιση του συνδρομου οξειας αναπνευστικης δυσχερειας (ards) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20220101078A GR1010617B (el) | 2022-12-23 | 2022-12-23 | Αναστολεις της προλυλικης ολιγοπεπτιδασης (ρορ) για χρηση στην προληψη και στην αντιμετωπιση του συνδρομου οξειας αναπνευστικης δυσχερειας (ards) |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1010617B true GR1010617B (el) | 2024-01-25 |
Family
ID=89983971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20220101078A GR1010617B (el) | 2022-12-23 | 2022-12-23 | Αναστολεις της προλυλικης ολιγοπεπτιδασης (ρορ) για χρηση στην προληψη και στην αντιμετωπιση του συνδρομου οξειας αναπνευστικης δυσχερειας (ards) |
Country Status (1)
Country | Link |
---|---|
GR (1) | GR1010617B (el) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1481669A1 (en) * | 2003-05-30 | 2004-12-01 | Yamanouchi Pharmaceutical Co. Ltd. | Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity |
US20210393580A1 (en) * | 2020-06-18 | 2021-12-23 | Horphag Research Ip (Pyc) Ltd | Procyanidins for the treatment of endothelial dysfunction triggered by covid-19 |
-
2022
- 2022-12-23 GR GR20220101078A patent/GR1010617B/el active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1481669A1 (en) * | 2003-05-30 | 2004-12-01 | Yamanouchi Pharmaceutical Co. Ltd. | Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity |
US20210393580A1 (en) * | 2020-06-18 | 2021-12-23 | Horphag Research Ip (Pyc) Ltd | Procyanidins for the treatment of endothelial dysfunction triggered by covid-19 |
Non-Patent Citations (2)
Title |
---|
XP021295769 * |
XP086566970 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Suzuki et al. | Sirtuin1 and autophagy protect cells from fluoride-induced cell stress | |
EA200870380A1 (ru) | Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета | |
CL2017001983A1 (es) | Composiciones farmacéuticas para terapia combinada. | |
UA99810C2 (ru) | Фармацевтические составы, которые содержат ингибиторы деацетилазы гистонов | |
EA200501805A1 (ru) | Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы | |
GEP20135724B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes | |
UA90521C2 (uk) | Фармацевтична композиція, що містить симвастатин і езетиміб | |
MX342128B (es) | Compuestos farmaceuticos. | |
NO20052690L (no) | Fenylalaninderivater som dipeptidylpeptidaseinhibitorer for behandlingen eller profylaksen av sukkersyke. | |
CR8163A (es) | Composicion farmaceutica que contiene un inhibidor de histona desacetilasa | |
MX2022014007A (es) | Compuestos como inhibidores de bcl-2. | |
BRPI0903359B8 (pt) | composição farmacêutica de metformina, ácido acetilsalicílico e composto de serotonina para o tratamento do câncer | |
Sriraksa et al. | Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma-cell line findings | |
TW200503668A (en) | Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors | |
DE602005020314D1 (de) | Bicyclononen-derivate als renin-inhibitoren | |
MX2022014303A (es) | Compuestos para el tratamiento del sars. | |
ZA202300259B (en) | Compound for the treatment of coronaviral infections | |
MX2022010960A (es) | Métodos y composiciones para tratar el trastorno por uso de cannabis y mitigar la abstinencia de cannabinoides. | |
GR1010617B (el) | Αναστολεις της προλυλικης ολιγοπεπτιδασης (ρορ) για χρηση στην προληψη και στην αντιμετωπιση του συνδρομου οξειας αναπνευστικης δυσχερειας (ards) | |
WO2022221528A3 (en) | Kras g12c inhibitors | |
TW200628468A (en) | Bicyclononene derivatives | |
AU2002215982A1 (en) | Topical treatment of mastalgia with arometese inhibitors such as androstendione | |
BR112018072298A2 (pt) | tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase | |
MX2022004476A (es) | Manejo temprano, mitigacion y prevencion de la sepsis y de sindromes similares a la sepsis, incluyendo el sindrome de dificultad respiratoria aguda neonatal debido a infeccion, lesion o iatrogenesis. | |
TW200621774A (en) | Bicyclononene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20240209 |